Syneron Medical (ELOS) Posts Q2 non-GAAP Loss of $0.12, In-Line with Views

August 12, 2010 7:44 AM EDT Send to a Friend
Syneron Medical Ltd. (Nasdaq: ELOS) reports Q2 non-GAAP loss of $0.12, even with the analyst estimate of ($0.12). Revenue for the quarter was $48.6 million, which compares to the estimate of $46.60 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Add Your Comment